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1. Introduction 
Tonin is a novel peptidase isolated and purified 
from the rat submaxillary gland [ 1,2]. It is capable of 
cleaving either angiotensinogen, the tetradecapeptide 
renin substrate, or angiotensin I to yield directly the 
octapeptide angiotensin II by the splitting of a phen- 
ylalanyl peptide bond. It is believed [2] that tonin 
plays an important role in regulating peripheral vascu- 
lar tone by controlling the formation of angiotensin 
II which is the most active known vasoconstrictor 
substance. Tonin was also shown to differ from angio- 
tensin I converting enzyme, renin and tissue isorenin 
PI. 
This enzyme has been purified to homogeneity and 
found to be a polypeptide containing 272 amino acids 
with a MW of 28 700 [2,3]. N-terminal sequence anal- 
ysis has permitted the identification of 34 of the first 
40 residues [3] and revealed an extensive homology 
with the sequence of many serine proteases of the 
trypsin-chymotrypsin family. 
We have recently demonstrated that tonin, which 
is present in the pituitary gland and in the brain [4], is 
capable of cleaving beta-lipotropin (beta-LPH) and 
adrenocorticotropin (ACTH) at. certain phenylalanyl 
and arginyl peptide bonds to produce a number of 
fragments, including an opioid-like material corre- 
sponding to portion 61-78 of beta-LPH [5]. 
The phenylalanyl cleavage sites of tonin with three 
different substrates (beta-LPH, ACTH and angio- 
tensinogen) [2,5] and the occurrence of two phenyl- 
alanine residues at positions 7 and 8 in substance P, a 
powerful vasodilating agent [6] led us to investigate 
the activity of tonin on substance P, an unadecapep- 
tide isolated and characterized by Leeman et al. [6]. 
2. Materials and methods 
The isolation, purification and characterization of 
rat tonin from submaxillary glands has already been 
described [l-3]. Synthetic substance P was pur- 
chased from Peninsula Labs., San Carlos, CA. The 
peptide was dissolved in 0.1M K2HP04 and digested 
at 37°C for different lengths of time at a variety of 
pHs. 
The C-terminus directed antiserum [8] showed a 
complete cross-reactivity with all the biologically 
active C-terminal fragments of substance P down to 
fragments 7-11, while the N-terminus directed anti- 
serum [7] cross-reacted only slightly with fragments 
2-l 1 and 3-l 1 and not at all with the other shorter 
C-terminal fragments of substance P. Using these two 
different antisera in conjunction, one may assess the 
approximate cleavage sites of enzymatic digestion of 
substance P. 
In a first series of experiments, 20 pg of substance 
P in a total volume of 25 /.d (0.6 mM) was digested 
with 2.5 and 5 clg of tonin (0.0035,0.007 mM) and 
the degradation of substance P was followed by 
radioimmunoassays using two different antisera, one 
directed against the N-terminus [7] and the other 
against the C-terminus portion of the molecule [8]. 
Incubation at pH 7.5 for 8 h were the most appropri- 
ate conditions for digestion. These conditions were 
used for the second series of experiments in which 
larger amounts of substance P (250 pg) were added, 
using the same substrate-enzyme ratio. The peptides 
obtained were separated by high performance liquid 
chromatography using a Waters Associates instrument, 
equipped with a Model 450 UV detector. The sample 
was applied on a Waters uBondapak Cl8 (3.9 X 30 cm) 
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column equilibrated with 5 : 95 (v/v) acetonitrile/lO 
mM ammonium acetate, pH 4.0 and eluted with a 20 
min linear gradient from 5 to 65% acetonitrile in 10 
mM ammonium acetate, pH 4.0 at a flow rate of 
2 ml/min. The position of substance P was identified 
with the same synthetic material used for the diges- 
tions. 
The peaks obtained were collected, dried and ana- 
lyzed for their amino acid composition following acid 
hydrolysis in 5.7 N of HCl at 110°C for 24 h. 
3. Results 
The disappearance of substance P immunoreac- 
tivity upon incubation at 37’C was both time- and 
pH-dependent. As shown in table 1, the more suit- 
able pH being between 7.5 and 8.5. The time course 
of digestion of substance P at pH 7.5 revealed that an 
8 h digestion degraded about 60% of substance P. 
Incubation of tonin alone under identical conditions 
did not give rise to any substance P like material. 
Since both N-terminal and C-terminal directed 
substance P radioimmunoassay results were compara- 
ble, there was no indication of any accumulation of 
C-terminal fragments longer than 7-l 1, and the phen- 
ylalanyl bonds were the most likely cleavage sites. 
This assumption was verified in the second series 
of experiments in which 250 pg of substance P was 
digested for 8 h at pH 7.5 at an enzyme-substrate 
molar ratio of l/80. Tonin degraded substance P into 
4 major peptide fragments which were separated by 
HPLC (fig. 1A). Peaks 1,2,3,4 were analysed for their 
amino acid composition. Peak 5 corresponds to stan- 
dard substance P, while peak 6 co-elutes with the 
enzyme (fig.lB). 
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Fig.1 (A) High performance liquid chromatographic separation 
of the peptrdes released in the digestion of substance P with 
tonin. The load was 250 ng dissolved in 50 ,nl of water; (B) 
Control digestion of tonin without substance P. 
Percentage of substance P remaining (? SEM) 
PH 
enzyme/substrate ratio 
4.0 
5.0 
6.8 
7.5 
8.5 
N-terminal antiserum C-terminal antrserum 
l/160 l/80 l/160 l/80 
119 k 13 68 +5 129 f 10 84 * 4 
141 i 16 45 kl 116 * 8 58 +-13 
3 ? 1 0.9 * 0.0 6 t 0.7 1 + 0.0 
0.00 f 0.0 0.54 + 0.3 2.24 f 0.1 0.3 + 0.0 
0.4 f 0.4 0.0 k 0.0 0.19 5 0.1 0.3 * 0.1 
Degradation of substance P (20 I.cg, 0.15 mmol) by rat tonin incubated for 24 h at 37°C. Each 
value is a mean of 4 determinations 
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Table 2 
Amino acid composition of purified peptides isolated by HPLC after an 8 h digest 
of substance P (250 rg) with tonin at enzyme-substrate ratio of 1 : 80 at 37°C 
and pH 7.5 
HPLC peaks 1 2 3 4 
Substance P l-7 9-13 l-8 8-11 
fragment Yield (45.5 nmol) (I 0.7 nmol) (7.9 nmol) (49.8 nmoI) 
Amino acid 
Glu 
Pro 
GUY 
Met 
Leu 
Phe 
LYS 
Arg 
2.09 
1.97 
0.02 
0.98 
1.01 
0.96 
2.18 
1.69 
1.06 0.23a 1.02 
0.90 0.97 
1.03 1.02 
2.0 1.0 
1.26 
0.85 
a Slightly contaminated by a glycine-containing peptide 
The amino acid composition of peaks 1 to 4 is 
shown in table 2. P, is identical to fragment 1-7, Pz 
to fragment 9-11, Pa to fragment l-8 and P4 to frag- 
ment 8-l 1 of substance P. The yields of each peptide 
also reveal that tonin, under this condition, digests 
substance P at the two phenylalanyl peptide bonds, 
being 5 times faster on the PP-PF bond than on the 
Pk-Giy bond. 
4. Discussion 
Tonin was previously found to cleave its substrate 
preferentially at certain phenylalanyl peptide bonds 
in angiotensin, beta-LPH and ACTH [ 1,2,5] while it 
also cleaves certain arginyl bonds in both beta-LPH 
and ACTH [5]. There is an arginine residue at the 
N-terminus of substance P,but it is unlikely to be 
split by tonin because it is next to a proline residue. 
There is no indication that the arginine was attacked, 
since no free arginine could be detected in the digest. 
This result is comparable to the resistance of other 
peptide substrates with Arg Pro sequences to tryptic 
digestion including substance P [6]. 
However, the preference of tonin for phenylalanyl 
bond cleavage was also found with substance P,which 
was mainly degraded at phenylalanine 7 and to a lesser 
extent at phenylalanine 8.Thus tonin which is present 
in the blood [2] and in the brain [4], might be 
involved in the degradation of substance P. This is 
interesting since the same nzyme (tonin) might act 
Arg-Pro-Lys-Pro-Gin-Gln-PheiPhekGly-Leu-Met-NH2 
12345678 9 10 11 
< 45.5 nmoIa , f 49.8 nmol , 
< 7.9 nmol f * 10.7 nmol , 
a Yields of peptides isolated from HPLC 
Fig.2. Cleavage sites of substance P digested by tonin. 
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on the vascular tone by simultaneously generating a 
vasoconstrictor substance (angiotensin II) and degrad- 
ing a vasodilator agent (substance P). It will be 
important to test the action of tonin on bradykinin, 
another circulating vasodilator factor which has 
phenylalanine at positions 5 and 8 of its amino acid 
sequence. 
Although tonin has a chymotrypsin-like activity, it 
is not chymotrypsin since it does not split tyrosine, 
tryptophan and other phenylalanine residues in the 
substrates already tested, i.e. angiotensinogen, beta- 
LPH and ACTH [25]. 
Finally, the activity of tonin on neuropeptides and 
its presence in the central nervous system [4] makes 
it worthwhile to study its importance in brain function. 
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